Rights & Society
EMA: New Medicines Development Tools
The European Medicines Agency (EMA) has launched new features for PRIME, its scheme to enhance support for developing medicines targeting unmet medical needs. These tools aim to accelerate the process of bringing innovative treatments to patients in the EU. The launch supports quicker assessments and pathways to market. The additions should reduce development bottlenecks.
Faster development of innovative EU medicines